The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
2021 European guideline on the management of Mycoplasma genitalium infections
Abstract
Mycoplasma genitalium infection contributes to 10–35% of non‐chlamydial non‐gonococcal urethritis in men. In women, M. genitalium is associated with cervicitis and pelvic inflammatory disease (PID) in 10–25%. Transmission of M. genitalium occurs through direct mucosal contact. Clinical features and diagnostic tests: Asymptomatic infections are frequent. In men, urethritis, dysuria and discharge predominate. In women, symptoms include vaginal discharge, dysuria or symptoms of PID – abdominal pain and dyspareunia. Symptoms are the main indication for diagnostic testing. Diagnosis is achievable only through nucleic acid amplification testing and must include investigation for macrolide resistance mutations. Therapy: Therapy for M .genitalium is indicated if M. genitalium is detected. Doxycycline has a cure rate of 30–40%, but resistance is not increasing. Azithromycin has a cure rate of 85–95% in macrolide‐susceptible infections. An extended course of azithromycin appears to have a higher cure rate, and pre‐treatment with doxycycline may decrease organism load and the risk of macrolide resistance selection. Moxifloxacin can be used as second‐line therapy but resistance is increasing. Recommended treatment: Uncomplicated M. genitalium infection without macrolide resistance mutations or resistance testing: Azithromycin 500 mg on day one, then 250 mg on days 2–5 (oral). Second‐line treatment and treatment for uncomplicated macrolide‐resistant M. genitalium infection: Moxifloxacin 400 mg od for 7 days (oral). Third‐line treatment for persistent M. genitalium infection after azithromycin and moxifloxacin: Doxycycline or minocycline 100 mg bid for 14 days (oral) may cure 40–70%. Pristinamycin 1 g qid for 10 days (oral) has a cure rate of around 75%. Complicated M. genitalium infection (PID, epididymitis): Moxifloxacin 400 mg od for 14 days. Main changes from the 2016 European M. genitalium guideline: Due to increasing antimicrobial resistance and warnings against moxifloxacin use, indications for testing and treatment have been narrowed to primarily involve symptomatic patients. The importance of macrolide resistance‐guided therapy is emphasised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACT
Tully, J., Cole, R., Taylor-Robinson, D., & Rose, D. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92461-2 · Cited by 576
Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
Taylor-Robinson, D., & Jensen, J. S. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-11 · Cited by 537
Self-citationMycoplasma genitalium Infection and Female Reproductive Tract Disease: A Meta-analysis
Lis, R., Rowhani-Rahbar, A., & Manhart, L. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ312 · Cited by 460
2016 European guideline on Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13849 · Cited by 343
Self-citationJensen, J. S., Bradshaw, C. S., Tabrizi, S. N., Fairley, C. K., & Hamasuna, R. (2008) · Clinical Infectious Diseases · doi:10.1086/593188 · Cited by 338
Self-citationAssociation between Mycoplasma genitalium and acute endometritis
Cohen, C. R., Manhart, L. E., Bukusi, E. A., Astete, S., Brunham, R. C., Holmes, K. K., Sinei, S. K., Bwayo, J. J., & Totten, P. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07848-0 · Cited by 307
Mucopurulent Cervicitis and Mycoplasma genitalium
Manhart, L. E., Critchlow, C. W., Holmes, K. K., Dutro, S. M., Eschenbach, D. A., Stevens, C. E., & Totten, P. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/367992 · Cited by 275
Machalek, D. A., Tao, Y., Shilling, H., Jensen, J. S., Unemo, M., Murray, G., Chow, E. P. F., Low, N., Garland, S. M., Vodstrcil, L. A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30154-7 · Cited by 273
Self-citationMycoplasma genitalium: prevalence, clinical significance, and transmission
Anagrius, C. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.012062 · Cited by 235
Schwebke, J. R., Rompalo, A., Taylor, S., Sena, A. C., Martin, D. H., Lopez, L. M., Lensing, S., & Lee, J. Y. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq074 · Cited by 235
Metadata
- Authors
- Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2022-02-19
- Volume
- 36
- Issue
- 5
- Pages
- 641-650
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W4213038453
- Cited by
- 255
- References
- 71
- FWCI
- 24.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 2021 European guideline on the management of Mycoplasma genitalium infections. https://app.cochat.ai/papers/10.1111/jdv.17972
- The paper
- Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M. (2022). 2021 European guideline on the management of Mycoplasma genitalium infections. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.17972
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.